A. Although Health Canada had suspended the sale of Adderall and Adderall XR, it is important to keep in mind that the FDA has stated that 'when one considers the rate of sudden death in pediatric patients treated with Adderall products based on the approximately 30 million prescriptions written between 1999 and 2003 (the period of time in which these deaths occurred), it does not appear that the number of deaths reported is greater than the number of sudden deaths that would be expected to occur in this population without treatment.'
And since that initial suspension, Adderall XR has been allowed back on the market in Canada.
The FDA does still advise that children should not take Adderall if they have:
- A heart defect
- Other heart problems, including high blood pressure, and heart or blood vessel disease
- Overactive thyroid
- A history of drug abuse
- Depression and are taking, or have recently stopped taking, an Monoamine Oxidase Inhibitor (MAOI), such as Nardil (phenelzine sulfate), Parnate (tranylcypromine sulfate), Marplan (isocarboxid), and other brands.
There is some contact information available on the FDA Adderall Patient Information Sheet, and you might call or email them to see what they say. Discussing this with your Pediatrician and Hematologist might also be helpful.
You might also contact the manufacturer, Shire Pharmaceuticals, and ask them.